Benzinga's Microcap Movers for Wednesday June 6, 2012

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Shares of Ascent Solar Technologies

, the Thornton, CO photovoltaic technology company, rose 48.28% Wednesday on almost 8 times the average daily volume. Ascent Solar Technologies announced Wednesday it has launched a charger for the Apple

iPhone 4/4S smart phone featuring Ascent's ultra light CIGS technology. Branded under Ascent's new EnerPlex line of consumer products, the charger incorporates the company's solar cells into a sleek, protective iPhone 4/4S case, along with a thin battery. The charger adds minimal weight and size to an iPhone smart phone, yet provides significantly improved battery life by harnessing sunlight for electric power. The first product in a forthcoming line of smart phone chargers from Ascent Solar, the EnerPlex product is designed specifically for the Apple iPhone. Ascent plans to introduce similar chargers for other smart phones, including the newly launched Samsung Galaxy SIII, in the near future. Ascent Solar Technologies closed at $0.86 on Wednesday.

Shares of Bio-Matrix Scientific Group (

), the La Mesa, CA biotechnology company, rose 111% Wednesday on 24 times the average daily volume. Bio-Matrix Scientific Group announced Wednesday that its Regen BioPharma unit has appointed three internationally renowned regenerative medicine experts to its Scientific Advisory Board. The new SAB members appointed are David White, M.D., PhD; Wei-Ping Min, M.D., PhD and Vlad Bogin, M.D. "Our strong SAB has scientific and regulatory expertise, coupled with Clinartis' access to world-class researchers and investigators will be very instrumental for accelerated commercialization of the cutting-edge biotechnology research on which Regen BioPharma is focused," according to Bio-Matrix Scientific Group's Chairman & CEO David Koos. Bio-Matrix Scientific Group closed at $0.006 on Wednesday.

Shares of Streamline Health Solutions

, the Cincinnati, OH provider of solutions that help hospitals and physician groups improve efficiencies and business processes across the enterprise to enhance and protect revenues, rose 25.33% Wednesday on 20 times the average daily volume. Streamline Health Solutions was initiated with a Buy Wednesday and a $5 price target at Craig-Hallum. Streamline Health Solutions closed at $2.82 on Wednesday.